HER2-Positive Breast Cancer: New Findings, Expanded Options, and an Evolving Treatment Paradigm

Learn from the experts how to leverage new and established HER2-targeting agents for optimal management of HER2+ early and metastatic breast cancer with these downloadable slides and on-demand Webcast.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Puma Biotechnology, Inc.

Seagen